These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19150703)

  • 1. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
    Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
    Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G; Walia M; Bala H; Singh S
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years.
    Marlow N; Morris T; Brocklehurst P; Carr R; Cowan FM; Patel N; Petrou S; Redshaw ME; Modi N; Dore C
    Arch Dis Child Fetal Neonatal Ed; 2013 Jan; 98(1):F46-53. PubMed ID: 22542709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
    Kuhn P; Messer J; Paupe A; Espagne S; Kacet N; Mouchnino G; Klosowski S; Krim G; Lescure S; Le Bouedec S; Meyer P; Astruc D
    J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor in the treatment of neonates with neutropenia and sepsis.
    Venkateswaran L; Wilimas JA; Dancy R; Wang WC; Korones S; Hayden J; Hayes FA
    Pediatr Hematol Oncol; 2000 Sep; 17(6):469-73. PubMed ID: 10989467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years.
    Marlow N; Morris T; Brocklehurst P; Carr R; Cowan F; Patel N; Petrou S; Redshaw M; Modi N; Doré CJ
    Arch Dis Child Fetal Neonatal Ed; 2015 Jul; 100(4):F320-6. PubMed ID: 25922190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
    Khan TH; Shahidullah M; Mannan MA; Nahar N
    Mymensingh Med J; 2012 Jul; 21(3):469-74. PubMed ID: 22828545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
    Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
    Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.